BioRestorative Therapies BRTX Growth Metrics (2010-2025)

NASDAQ BRTX
$2.33 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

BioRestorative Therapies Quarterly Growth Metrics

Periods 62 quarters
Latest Dec 2025

BioRestorative Therapies growth metrics data for the quarter ended Dec 2025. These growth metrics cover 62 quarters of results from Sep 2010 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y)
-8.05M-2.13M-4.19M-7.49M5.21M1.71M3.01M-4.59M1.31M0.17M0.58M10.92M0.67M0.21M0.90M1.04M-0.74M0.16M-3.00M-1.32M
EBITDA Margin Growth (3y)
-7.21M-1.82M-4.15M-7.24M-2.36M0.02M-1.11M-11.91M-1.54M-0.25M-0.61M-1.16M7.19M2.08M4.49M7.37M1.24M0.54M-1.52M10.64M
EBITDA Margin Growth (5y)
-6.15M-1.07M-1.28M-5.00M0.32M0.61M-0.53M-12.17M-0.69M0.06M-0.56M-0.92M-0.38M0.40M0.37M0.05M-1.60M0.12M-2.71M-1.44M
EBITDA Margin (QoQ)
-7.86M5.99M-2.23M-3.39M4.83M2.50M-0.93M-10.99M10.73M1.36M-0.52M-0.65M0.48M0.89M0.18M-0.51M-1.29M1.80M-2.99M1.17M
EBIT Margin Growth (1y)
-8.05M-2.13M-4.20M-7.52M5.21M1.72M3.02M-4.64M1.31M0.17M0.58M10.99M0.67M0.21M0.91M1.05M-0.75M0.17M-3.05M-1.33M
EBIT Margin Growth (3y)
-7.19M-1.82M-4.15M-7.27M-2.36M0.04M-1.11M-11.98M-1.53M-0.24M-0.60M-1.17M7.19M2.09M4.51M7.40M1.24M0.54M-1.55M10.70M
EBIT Margin Growth (5y)
-6.10M-1.04M-1.18M-4.94M0.40M0.63M-0.50M-12.24M-0.67M0.07M-0.55M-0.92M-0.37M0.41M0.38M0.05M-1.61M0.13M-2.74M-1.45M
EBIT Margin (QoQ)
-7.86M5.99M-2.24M-3.41M4.86M2.51M-0.94M-11.06M10.81M1.36M-0.53M-0.66M0.49M0.90M0.18M-0.52M-1.30M1.81M-3.03M1.19M
EBT Margin Growth (1y)
-8.05M-2.12M-4.82M-7.52M5.21M1.72M3.63M-4.64M1.31M0.17M0.59M10.99M0.67M0.21M0.91M1.05M-0.75M0.17M-3.05M-1.33M
EBT Margin Growth (3y)
-7.19M-1.82M-4.77M-7.27M-2.36M0.04M-1.12M-11.98M-1.53M-0.24M-0.60M-1.17M7.19M2.09M5.13M7.40M1.24M0.54M-1.54M10.70M
EBT Margin Growth (5y)
-6.05M-1.06M-1.80M-4.94M0.40M0.63M-0.51M-12.24M-0.67M0.07M-0.55M-0.92M-0.37M0.41M0.38M0.05M-1.61M0.14M-2.73M-1.45M
EBT Margin (QoQ)
-7.86M5.99M-2.86M-2.79M4.86M2.51M-0.95M-11.05M10.81M1.36M-0.53M-0.66M0.49M0.90M0.18M-0.52M-1.30M1.81M-3.03M1.19M
FCF Margin Growth (1y)
-0.28M-0.27M-0.44M-1.95M-0.61M0.30M0.29M-2.19M0.29M-0.01M0.10M3.62M0.12M-0.01M0.31M0.31M-0.47M0.12M-2.38M-0.72M
FCF Margin Growth (3y)
0.16M-0.21M-0.27M-1.75M-0.38M0.26M-0.04M-3.92M-0.61M0.02M-0.04M-0.52M-0.21M0.29M0.71M1.74M-0.07M0.11M-1.97M3.22M
FCF Margin Growth (5y)
1.53M0.17M1.69M-0.53M0.68M0.19M-0.17M-4.12M-0.17M0.08M0.13M-0.32M0.02M0.25M0.38M0.02M-0.96M0.13M-2.11M-0.93M
FCF Margin (QoQ)
-0.12M-0.04M-0.29M-1.50M1.22M0.87M-0.30M-3.99M3.70M0.58M-0.18M-0.47M0.20M0.45M0.13M-0.47M-0.59M1.05M-2.37M1.19M
Gross Margin Growth (1y)
-728.00-781.00-771.00-0.00M441.00-0.01M-64.00
Gross Margin Growth (3y)
Gross Margin Growth (5y)
Gross Margin (QoQ)
0.00M0.00M0.00M-728.00-53.0010.00-392.00876.00-0.01M0.01M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
84.98%-2,047.21%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
Net Margin Growth (1y)
-5.79M-4.22M-4.67M-37.42M3.57M3.14M3.35M33.59M2.84M-1.32M3.43M6.02M1.66M0.43M-1.60M0.82M-1.50M0.36M-2.53M-1.26M
Net Margin Growth (3y)
-7.38M-1.76M-4.11M-39.58M-3.79M1.78M-0.55M-6.73M0.61M-2.40M2.11M2.20M8.06M2.26M5.18M40.43M2.99M-0.52M-0.70M5.58M
Net Margin Growth (5y)
-5.97M-1.31M-1.56M-37.42M-1.15M1.81M-0.60M-6.72M-0.97M0.06M2.68M0.04M0.70M0.89M1.28M0.11M0.77M-1.60M-2.02M1.75M
Net Margin (QoQ)
-5.31M5.99M-2.52M-35.58M35.68M5.57M-2.31M-5.33M4.92M1.41M2.44M-2.75M0.56M0.18M0.41M-0.33M-1.76M2.05M-2.49M0.94M
Operating Margin Growth (1y)
-8.05M-2.13M-4.20M-7.52M5.21M1.72M3.02M-4.64M1.31M0.17M0.58M10.99M0.67M0.21M0.91M1.05M-0.75M0.17M-3.05M-1.33M
Operating Margin Growth (3y)
-7.19M-1.82M-4.15M-7.27M-2.36M0.04M-1.11M-11.98M-1.53M-0.24M-0.60M-1.17M7.19M2.09M4.51M7.40M1.24M0.54M-1.55M10.70M
Operating Margin Growth (5y)
-6.10M-1.04M-1.18M-4.94M0.40M0.63M-0.50M-12.24M-0.67M0.07M-0.55M-0.92M-0.37M0.41M0.38M0.05M-1.61M0.13M-2.74M-1.45M
Operating Margin (QoQ)
-7.86M5.99M-2.24M-3.41M4.86M2.51M-0.94M-11.06M10.81M1.36M-0.53M-0.66M0.49M0.90M0.18M-0.52M-1.30M1.81M-3.03M1.19M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.01M-0.03M-0.07M-0.01M0.03M0.05M0.08M0.01M-0.01M-0.00M-0.00M-463.000.00M0.01M0.00M0.00M-0.00M-0.01M-0.01M-0.02M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.01M0.00M-0.04M0.04M0.05M0.03M0.03M0.05M0.04M0.02M0.01M-0.00M0.03M0.05M0.09M0.01M-0.00M-0.01M-0.01M-0.02M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.00M-0.02M0.05M0.05M0.05M0.04M0.04M0.05M0.05M0.05M0.05M0.03M0.04M0.05M0.04M0.02M0.01M-0.02M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-0.03M-0.02M-0.03M0.07M0.01M-0.00M-954.00-0.00M-0.00M-376.00995.00786.000.00M0.00M-301.00-731.00-0.00M-0.00M-0.01M-0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.02M0.14M-0.01M0.04M0.09M0.12M0.01M-0.00M-0.05M0.00M0.00M0.01M0.05M0.00M0.00M-0.01M-0.01M-0.03M-0.13M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.03M0.26M534.000.05M0.09M0.13M0.01M0.01M-0.01M-0.02M-0.12M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.06M0.24M-0.12M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.05M-0.04M-0.04M0.12M-0.00M0.01M-0.00M88.00-0.01M-0.03M0.04M0.00M0.00M437.00-213.00-712.00-0.01M-0.01M-0.02M-0.10M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.07M-0.00M-0.02M-0.01M0.00M0.01M0.03M0.01M0.00M-0.01M-0.01M-0.03M-0.11M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.08M0.00M-0.00M-0.02M-0.10M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.07M337.000.00M-0.00M-0.00M-0.02M0.02M0.01M0.00M859.00-0.00M-850.00-0.00M-0.01M-0.02M-0.08M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-8.05M-2.13M-4.20M-7.52M5.21M1.72M3.02M-4.64M1.31M0.17M0.58M10.99M0.67M0.21M0.91M1.05M-0.75M0.17M-3.05M-1.33M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-7.19M-1.82M-4.15M-7.27M-2.36M0.04M-1.11M-11.98M-1.53M-0.24M-0.60M-1.17M7.19M2.09M4.51M7.40M1.24M0.54M-1.55M10.70M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-6.10M-1.04M-1.18M-4.94M0.40M0.63M-0.50M-12.24M-0.67M0.07M-0.55M-0.92M-0.37M0.41M0.38M0.05M-1.61M0.13M-2.74M-1.45M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-7.86M5.99M-2.24M-3.41M4.86M2.51M-0.94M-11.06M10.81M1.36M-0.53M-0.66M0.49M0.90M0.18M-0.52M-1.30M1.81M-3.03M1.19M

BioRestorative Therapies Growth Metrics API

Pull BioRestorative Therapies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BRTX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY